← Open Payments lookup

KENDALL DYKE: Open Payments

NPI 1558029173 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$447 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $947 · 2025 $447

Food & beverage: $447
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$176
Merck Sharp & Dohme LLC2$56
Deciphera Pharmaceuticals Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.1$34
Novartis Pharmaceuticals Corporation1$27
Daiichi Sankyo Inc.1$27
BeOne Medicines USA, Inc.1$27
Incyte Corporation1$23
Janssen Biotech, Inc.1$22
SpringWorks Therapeutics, Inc.1$20

Products named: IMFINZI, KEYTRUDA, QINLOCK, ICLUSIG, LYNPARZA, KISQALI, INJECTAFER, BRUKINSA.

Industry payments across SD — which companies pay providers there.